Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 2651–2700 of 18397
On January 3, 2025, the Company accepted the resignation from Emil Assentato as the Company's Chief Financial Officer.
On January 21, 2025, the Company’s Board of Directors approved the appointment of Jason Maddox, the Company’s President, as Interim Chief Financial Officer of the Company, effective immediately.
On January 20, 2025, William C. Miller provided notice to Envirotech Vehicles, Inc., a Delaware corporation (the “Company”), of his intention to resign as the Company’s Chief Financial Officer, effective immediately.
appointed Ryan Polk, 56, as interim Chief Financial Officer, Treasurer and Secretary of the Company, effective as of February 14, 2025
resignation of Mr. Hinojosa from the positions of the Company’s Chief Financial Officer, Treasurer and Secretary, effective February 14, 2025
the appointment of Mr. Ryan Lada to succeed Mr. Clifford as Senior Vice President, Chief Financial Officer and Treasurer of the Company and the appointment of Mr. Matthew Wiora as Chief Accounting Officer of the Company, in each case effective simultaneously with Mr. Clifford’s resignation on January 24, 2025.
the appointment of Mr. Ryan Lada to succeed Mr. Clifford as Senior Vice President, Chief Financial Officer and Treasurer of the Company and the appointment of Mr. Matthew Wiora as Chief Accounting Officer of the Company, in each case effective simultaneously with Mr. Clifford’s resignation on January 24, 2025.
President / Chief Executive Officer George Pappi, Jr.
Vice President - Finance / Chief Financial Officer Suzanne Colvin
appointed Michael P. Lyons to serve as the Company’s President and CEO-Elect, effective as of January 27, 2025
Adam Desmond, the Company’s current CEO, will serve as the Interim CFO until a permanent CFO is identified.
On January 17, 2025, James Creamer tendered his resignation as Chief Financial Officer of Selectis Health, Inc. (the “Company”), pursuant to a Separation Agreement and Release of even date.
Mr. Boris Molchadsky, the Company’s Chairman, will assume the position of Chief Executive Officer.
On January 19, 2025, SleepX Ltd., a company established in the State of Israel (“SleepX”) and wholly-owned subsidiary of AppYea, Inc., a Nevada corporation (the “Company”) and Mr. Adi Shemer (“AS”) agreed to terminate AS’ position as Chief Executive Officer of the Company.
On January 17, 2025, Mr. Eric Sherb, CPA, of EMS Consulting Services, was appointed as the Company’s Chief Financial Officer.
Ms. Pinto resigned as the interim Chief Financial Officer effective as of the same date and will remain the Company’s Senior Vice President, Finance and Chief Accounting Officer and the principal accounting officer.
Effective January 21, 2025, the Board of Directors (the “Board”) of ALX Oncology Holdings Inc. (the “Company”) appointed Harish Shantharam to the office of Chief Financial Officer
David Stefko, a member of the Board currently serving as the Company’s Interim Chief Executive Officer, will step down as Interim Chief Executive Officer at that time.
Brendan Hoffman, co-founder and co-CEO of P-180, Inc., age 56, is expected to be appointed as the Company’s Chief Executive Officer effective on or around February 3, 2025, subject to mutual agreement on the terms of his employment.
Today, Everest Group, Ltd. (the "Company") announced that its Board of Directors has appointed Jim Williamson as President and Chief Executive Officer, effective immediately.
On January 17, 2025, the board of directors (the "Board") of Grocery Outlet Holding Corp. (the "Company" or "Grocery Outlet") appointed Jason Potter as President and Chief Executive Officer of the Company, effective February 3, 2025.
On January 15, 2025, Jim Behling notified the Company of his intent to resign as Chief Financial Officer (“CFO”) of The Real Good Food Company, Inc. (the “Company”), effective January 24, 2025.
Jeffrey Harris has announced his intention to separate from his position as the Company’s CEO and an employee of the Company.
On January 15, 2025 (the “Effective Date”), the Board of Directors (the “Board”) of Sanara MedTech Inc. (the “Company”) appointed Elizabeth B. Taylor to serve as the Chief Financial Officer of the Company, including the role of principal financial officer, effective as of the Effective Date.
(c) On January 21, 2025, the Board of Directors of the Company (the “Board”) appointed Mr. John F. Wyskiel as President and CEO of the Company, effective February 17, 2025.
our current President and CEO, Mr. Philip Horlock, will resign from those positions effective as of the close of business on February 16, 2025.
On January 21, 2025, Geoff Trukenbrod, Chief Financial Officer of LanzaTech Global, Inc. (the “Company”), resigned from the Company effective immediately
appointed Justin D. Pugh, to serve as interim Chief Financial Officer commencing January 21, 2025.
the Board conditionally appointed Mr. Ron Gusek, named successor to the Chief Executive Officer of the Company, as a Class II director
the previously disclosed resignation of Mr. Chris Wright as Chairman of the Board, Director, and CEO of the Company subject to his ratification and confirmation (the “Confirmation Condition”) by the United States Senate to serve as the incoming Secretary of Energy of the United States.
On January 19, 2025, the Board of Directors (the “Board”) of Berry Corporation (bry) (the “Company”) appointed Jeff Magids as Vice President, Chief Financial Officer (serving as the Company’s principal financial officer), effective January 21, 2025.
On January 10, 2025, the Board unanimously approved and elected Joseph Riccelli Jr.as a member of the Board and unanimously approved and elected Mr. Riccelli as the permanent Chief Executive Officer, effective immediately.
Chris Carlson ceased to serve as the Company's Chief Financial Officer
Benjamin P. Cowart ceased to serve as the Company's Chief Executive Officer
Mark Smith was appointed as the Reorganized Company's Chief Executive Officer on the Effective Date
the appointment of Michael C. Creedon, Jr. as Chief Executive Officer of the Company.
Michelle Brennan will cease to serve as Interim Chief Executive Officer of the Company
appointed Catherine Szyman, 58, as Chief Executive Officer of the Company, effective as of February 12, 2025
On January 15, 2025, Richard D. Roomberg, Chief Financial Officer of the Company, notified the Company that he will resign from all roles with the Company and its subsidiaries effective as of February 14, 2025.
On January 17, 2025, Vicarious Surgical Inc. (the “Company”) entered into a consulting agreement (the “Consulting Agreement”) with William Kelly in connection with Mr. Kelly’s previously disclosed departure from his role as Chief Financial Officer of the Company.
Effective on January 14, 2025, David Finn was appointed as Chief Financial Officer of Patriot and the Bank.
On January 15, 2025, we appointed Tom Symonds as Chief Executive Officer. Mr. Symonds has also been appointed to our Board of Directors.
Effective January 14, 2025, Manfred Ebensberger resigned as our Chief Executive Officer and Director.
On January 14, 2025, Adarsh Parekh was appointed as Chief Financial Officer of the Company, effective January 27, 2025.
On January 21, 2025, Medtronic plc (Company) announced the appointment of Thierry Pieton, age 54, as the Company’s Executive Vice President and Chief Financial Officer (CFO), effective as of March 3, 2025 (Effective Date).
the Board of Directors of the Company appointed Lance Wilson as the Company’s new Chief Financial Officer, to fill the vacancy in the position left after Alex Valdes’s resignation as Chief Financial Officer effective January 2, 2025.
Alex Valdes’s resignation as Chief Financial Officer effective January 2, 2025.
On January 14, 2025, the Board of Directors (the “Board”) of Sonder Holdings Inc. (the “Company”) appointed Michael Hughes as the Company’s Chief Financial Officer, effective January 22, 2025.
On January 14, 2025, the State Street Board of Directors appointed Mark R. Keating as interim CFO, effective upon Mr. Aboaf’s departure.
As previously disclosed, in October 2024 Eric Aboaf informed State Street Corporation (“State Street”) of his intention to step down from his roles as State Street’s Vice Chairman and Chief Financial Officer (“CFO”) in February 2025 to take a position with a firm outside of banking.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.